Effect of adrenal steroids on vasopressin-stimulated PGE synthesis and water flow.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology*; D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001127:Arginine Vasopressin / Q000494:pharmacology*; D001834:Body Water / Q000502:physiology*; D002024:Bufo marinus; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D066298:In Vitro Techniques; D011374:Progesterone / Q000494:pharmacology; D011458:Prostaglandins E / Q000096:biosynthesis*; D012964:Sodium / Q000378:metabolism; D013148:Spironolactone / Q000494:pharmacology; D014221:Triamcinolone / Q000494:pharmacology; D001743:Urinary Bladder / Q000187:drug effects* / Q000502:physiology; D014667:Vasopressins / Q000031:analogs & derivatives*
D000305:Adrenal Cortex Hormones; D001095:Arachidonic Acids; D011458:Prostaglandins E; D014667:Vasopressins; D001127:Arginine Vasopressin; D003609:Dactinomycin; D014221:Triamcinolone; D013148:Spironolactone; D000450:Aldosterone; D011374:Progesterone; D003907:Dexamethasone; D003513:Cycloheximide; D012964:Sodium